Resultats de la cerca - Ella Ekholm
- Mostrar 1 - 4 resultats de 4
-
1
Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment per... per Eiichi Araki, Yukiko Onishi, Michiko Asano, Hyosung Kim, Ella Ekholm, Eva Johnsson, Toshitaka Yajima
Publicat 2015Artigo -
2
-
3
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes per S. Matthäei, Doina Catrinoiu, Aleksander Celiñski, Ella Ekholm, W. James Cook, Boaz Hirshberg, Hungta Chen, Nayyar Iqbal, Lars Hansen
Publicat 2015Artigo -
4
Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes per Chantal Mathieu, Aurelian Emil Ranetti, Danshi Li, Ella Ekholm, W. James Cook, Boaz Hirshberg, Hungta Chen, Lars Hansen, Nayyar Iqbal
Publicat 2015Artigo
Eines de cerca:
Matèries relacionades
Dapagliflozin
Diabetes mellitus
Endocrinology
Internal medicine
Medicine
Type 2 diabetes
Alternative medicine
Glycemic
Hypoglycemia
Metformin
Pathology
Placebo
Saxagliptin
Sitagliptin
Adverse effect
Dipeptidyl peptidase-4 inhibitor
Gastroenterology
Insulin
Postprandial
Randomized controlled trial
Urology
Clinical endpoint
Continuous glucose monitoring
Glycated hemoglobin
Insulin glargine
Interim analysis
Pharmacology